Data Report
Covid19 => Covid Treatments => Topic started by: Steve on September 18, 2023, 07:37:55 pm
-
SUMMARY - A company called "60 Degrees Pharmaceuticals" has withdrawn a study application to the United States (US) Food and Drug Administration (FDA) concerning a drug that the company is developing, Tafenoquine (branded as Arakoda), for use concerning Covid-19. Tafenoquine has already been approved for the prevention of malaria.
LINK - https://news.yahoo.com/60-degrees-pharma-withdraws-mid-212041786.html (https://news.yahoo.com/60-degrees-pharma-withdraws-mid-212041786.html)